| Primary |
| Diabetes Mellitus |
57.1% |
| Pneumonia |
28.6% |
| Multiple Myeloma |
14.3% |
|
| Hypoglycaemia |
50.0% |
| Haemolytic Anaemia |
25.0% |
| Therapeutic Response Decreased |
25.0% |
|
| Secondary |
| Diabetes Mellitus |
36.7% |
| Hypertension |
17.0% |
| Rheumatoid Arthritis |
8.7% |
| Type 2 Diabetes Mellitus |
6.6% |
| Angina Pectoris |
3.7% |
| Drug Use For Unknown Indication |
3.2% |
| Insomnia |
3.2% |
| Constipation |
2.3% |
| Dermatitis Allergic |
1.9% |
| Gastritis |
1.8% |
| Hyperlipidaemia |
1.8% |
| Myocardial Infarction |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Cerebral Infarction |
1.6% |
| Diabetes Mellitus Insulin-dependent |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Bronchitis |
1.3% |
| Renal Transplant |
1.3% |
| Cardiac Failure |
1.1% |
| Hypercholesterolaemia |
1.1% |
|
| Hypoglycaemia |
24.1% |
| Liver Disorder |
10.2% |
| Hypoglycaemic Coma |
6.5% |
| Hepatic Function Abnormal |
5.6% |
| Pneumatosis Intestinalis |
5.6% |
| Pain |
4.6% |
| Pneumonia Cytomegaloviral |
4.6% |
| Toxic Epidermal Necrolysis |
4.6% |
| Nephrotic Syndrome |
3.7% |
| Peripheral Ischaemia |
3.7% |
| Platelet Count Decreased |
3.7% |
| Gastroenteritis Eosinophilic |
2.8% |
| Hyperkalaemia |
2.8% |
| Ileus |
2.8% |
| Pyrexia |
2.8% |
| Toxic Skin Eruption |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Convulsion |
1.9% |
| Decreased Appetite |
1.9% |
|
| Concomitant |
| Diabetes Mellitus |
23.6% |
| Hypertension |
17.7% |
| Rheumatoid Arthritis |
9.9% |
| Prophylaxis |
7.6% |
| Drug Use For Unknown Indication |
6.9% |
| Product Used For Unknown Indication |
5.5% |
| Constipation |
3.9% |
| Type 2 Diabetes Mellitus |
3.8% |
| Hyperlipidaemia |
2.9% |
| Gastritis |
2.6% |
| Cardiac Failure |
2.1% |
| Angina Pectoris |
2.0% |
| Insomnia |
1.9% |
| Hepatitis C |
1.7% |
| Hepatic Neoplasm Malignant |
1.6% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.4% |
| Cerebral Infarction |
1.3% |
| Gastric Ulcer |
1.3% |
| Atrial Fibrillation |
1.3% |
| Multiple Myeloma |
1.2% |
|
| Hypoglycaemia |
8.1% |
| Renal Impairment |
8.1% |
| Interstitial Lung Disease |
7.5% |
| Pyrexia |
7.3% |
| Vomiting |
6.6% |
| White Blood Cell Count Decreased |
6.3% |
| Hepatic Function Abnormal |
5.9% |
| Renal Failure Acute |
5.3% |
| Rash |
5.1% |
| Rhabdomyolysis |
4.9% |
| Pneumonia |
4.8% |
| Cardiac Failure |
3.7% |
| Cerebral Infarction |
3.7% |
| Diabetes Mellitus |
3.7% |
| Liver Disorder |
3.7% |
| Platelet Count Decreased |
3.4% |
| Sepsis |
3.1% |
| Loss Of Consciousness |
2.9% |
| Malaise |
2.9% |
| Somnolence |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
62.6% |
| Drug Use For Unknown Indication |
9.3% |
| Tuberculous Pleurisy |
9.3% |
| Onychomycosis |
3.7% |
| Pain |
3.7% |
| Pyrexia |
3.7% |
| Cardiac Failure |
1.9% |
| Constipation |
1.9% |
| Diabetes Mellitus |
1.9% |
| Gastritis |
1.9% |
|
| Drug Interaction |
42.9% |
| Hepatitis Fulminant |
28.6% |
| Condition Aggravated |
14.3% |
| Dementia |
14.3% |
|
